Homeopathic treatment of piles
- Conditions
- Health Condition 1: K648- Other hemorrhoids
- Registration Number
- CTRI/2018/10/016129
- Lead Sponsor
- ational Institute Of Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
a) Both male and female patients
b) Age between 18 and 65 years
c) Suffering from internal idiopathic haemorrhoids presenting with any of the symptoms, namely, bleeding, pain (including discomfort and tenesmus during defecation or any other time), heaviness, pruritus, and mucous discharge with or without anitis
d) Patients with known but controlled any other systemic illnesses
e) Patients using topical agents, subject to persistence of symptoms and signs of piles
1. Grade IV piles, external hemorrhoids, anal fissure and fistula
2. Hereditary piles, inflammatory bowel disease, enlarged prostate, previous history of surgery for hemorrhoids, hypertrophic anal papillae, and rectal malignancies.
3. Coagulation disorders, history of leukemic disorders
4. Patients with obstruction of portal circulation, pregnancy leading to obstruction of the portal circulation, lactating mothers.
5. Patients with psychiatric diseases.
6. Chronic alcoholism
7. Recreational drug or substance abuse
8. Pre-existing chronic debilitating illness
9. Subjects on hormonal contraceptives, Steroids or Non steroidal Anti-inflammatory Drugs (NSAIDs).
10. Any uncontrolled systemic, and life- threatening illness.
11. Self reported immune-compromised patients.
12. Undergoing homeopathic treatment for any chronic disease within last 6 months.
13. Unwilling to take part and not giving consent to join the study
14. Unable to read patient information sheet.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 0-10 numeric rating scales measuring intensity of symptoms of haemorrhoids (bleeding, pain, heaviness, discharge, and itching) and anoscopic examination scoresTimepoint: At baseline, 6 weeks and 12 weeks
- Secondary Outcome Measures
Name Time Method SF 12 questionnaire measures of quality of lifeTimepoint: At baseline, 6 weeks and 12 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.